Related references
Note: Only part of the references are listed.AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence
Patrick M. McCarthy et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer
Sandeep Pallerla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Rational design of innate defense regulator peptides as tumor vaccine adjuvants
Yaomei Tian et al.
NPJ VACCINES (2021)
Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement
Federica Sicca et al.
VACCINE (2020)
Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer
Parvin Zamani et al.
EUROPEAN JOURNAL OF CANCER (2020)
Synthetic and immunological studies on the OCT4 immunodominant motif antigen-based anti-cancer vaccine
Tingting Chen et al.
CANCER BIOLOGY & MEDICINE (2020)
P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer
Niloofar Farzad et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
SEOM clinical guidelines in early stage breast cancer (2018)
F. Ayala de la Pena et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model
Jennifer Lambrano et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Comparison of in vivo toxicity, antioxidant and immunomodulatory activities of coconut, nipah and pineapple juice vinegars
Nurul Elyani Mohamad et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2018)
Immunogenicity and antitumor activity of the superlytic lambda F7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice
Nastaran Barati et al.
CANCER LETTERS (2018)
Developing anti-HER2 vaccines: Breast cancer experience
Aydah Al-Awadhi et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu et al.
ONCOIMMUNOLOGY (2018)
Multi-epitope vaccines: a promising strategy against tumors and viral infections
Lifang Zhang
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
The clinical development of vaccines for HER2+ breast cancer: Current landscape and future perspectives
R. L. B. Costa et al.
CANCER TREATMENT REVIEWS (2017)
B cell regulation in cancer and anti-Xtumor immunity
Anushruti Sarvaria et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
Joshua Tobias et al.
BMC CANCER (2017)
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain
Keith L. Knutson et al.
CANCER RESEARCH (2016)
Peptide-based synthetic vaccines
Mariusz Skwarczynski et al.
CHEMICAL SCIENCE (2016)
Designing string-of-beads vaccines with optimal spacers
Benjamin Schubert et al.
GENOME MEDICINE (2016)
Peptide vaccines in breast cancer: The immunological basis for clinical response
Livia de Paula Peres et al.
BIOTECHNOLOGY ADVANCES (2015)
Adjuvant HER2/neu peptide cancer vaccines in breast cancer
Guy T. Clifton et al.
IMMUNOTHERAPY (2015)
A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy
Pravin T. P. Kaumaya
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Self-adjuvanting vaccine against group A streptococcus: Application of fibrillized peptide and immunostimulatory lipid as adjuvant
Fazren Azmi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies
Ashwin Swaminathan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Guidance for peptide vaccines for the treatment of cancer
Yoshiyuki Yamaguchi et al.
CANCER SCIENCE (2014)
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells
Sarah E. Church et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge
Fushun Zhang et al.
VIROLOGY JOURNAL (2014)
Recent progress in adjuvant discovery for peptide-based subunit vaccines
Fazren Azmi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Ursula Wiedermann et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
Rajesh T. Gandhi et al.
VACCINE (2009)
A promising balanced Th1 and Th2 directing immunological adjuvant, saponins from the root of Platycodon grandiflorum
Yong Xie et al.
VACCINE (2008)
Identification and characterization of keyhole limpet hemocyanin N-glycans mediating cross-reactivity with Schistosoma mansoni
H Geyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: Implications for vaccine development
RJ May et al.
JOURNAL OF IMMUNOLOGY (2003)
Share Paper
